Eribulin mesylate in patients with refractory cancers: a Phase I study

Por Mukohara, Toru, Nagai, Shunji, Mukai, Hirofumi, Namiki, Masayuki, Minami, Hironobu
Publicado em 2011

Overexpression of Endothelial Nitric Oxide Synthase in Endothelial Cells Is Protective against Ischemia-Reperfusion Injury in Mouse Skeletal Muscle

Por Ozaki, Masanori, Kawashima, Seinosuke, Hirase, Tetsuaki, Yamashita, Tomoya, Namiki, Masayuki, Inoue, Nobutaka, Hirata, Ken-ichi, Yokoyama, Mitsuhiro
Publicado em 2002

Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer

Por Farrell, Colm, Schweizer, Charles, Wustner, Jason, Weil, Susan, Namiki, Masayuki, Nakano, Tomohisa, Nakai, Kenya, Phillips, Martin D.
Publicado em 2012

Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer

Por Mukai, Hirofumi, Saeki, Toshiaki, Shimada, Ken, Naito, Yoichi, Matsubara, Nobuaki, Nakanishi, Tadashi, Obaishi, Hiroshi, Namiki, Masayuki, Sasaki, Yasutsuna
Publicado no Invest New Drugs (2014)

Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors

Por Fujisaka, Yasuhito, Kurata, Takayasu, Tanaka, Kaoru, Kudo, Toshihiro, Okamoto, Kunio, Tsurutani, Junji, Kaneda, Hiroyasu, Okamoto, Isamu, Namiki, Masayuki, Kitamura, Chifumi, Nakagawa, Kazuhiko
Publicado no Invest New Drugs (2014)

Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice

Por Ozaki, Masanori, Kawashima, Seinosuke, Yamashita, Tomoya, Hirase, Tetsuaki, Namiki, Masayuki, Inoue, Nobutaka, Hirata, Ken-ichi, Yasui, Hiroyuki, Sakurai, Hiromu, Yoshida, Yuichi, Masada, Masahiro, Yokoyama, Mitsuhiro
Publicado em 2002

A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors

Por Sasaki, Yasutsuna, Miwa, Keisuke, Yamashita, Keishi, Sunakawa, Yu, Shimada, Ken, Ishida, Hiroo, Hasegawa, Kosei, Fujiwara, Keiichi, Kodaira, Makoto, Fujiwara, Yasuhiro, Namiki, Masayuki, Matsuda, Minami, Takeuchi, Yutaka, Katsumata, Noriyuki
Publicado no Invest New Drugs (2014)